{
  "trial_id": "NCT00130247",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Adults, male or female, aged 18-60",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Newly diagnosed initial episodes of pulmonary tuberculosis",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Sputum smear-positive and -negative patients are eligible for enrollment",
      "label": "met",
      "evidence": "inclusion criteria"
    },
    {
      "criterion": "The diagnosis of tuberculosis must be confirmed by culture",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Chest X-ray and clinical findings consistent with tuberculosis",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Hemoglobin greater than or equal to 8 gm/dL (greater than or equal to 5.0 mmol/L)",
      "label": "met",
      "evidence": "lab study"
    },
    {
      "criterion": "Serum creatinine < 2 mg/dL (< 177 micro mol/L)",
      "label": "met",
      "evidence": "lab study"
    },
    {
      "criterion": "Serum aspartate aminotransferase (AST) < 1.5 times the upper limit of normal for the testing laboratory",
      "label": "met",
      "evidence": "lab study"
    },
    {
      "criterion": "Random serum glucose less than or equal to 150 mg/dl (8.3 mmol/L)",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Ambulatory",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Willing to provide informed consent for study participation, provide required specimens for examination, and to undergo and receive results of human immunodeficiency virus (HIV) testing",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Willing to receive supervised anti-TB treatment",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Completion of the required 112 doses of chemotherapy within 18 weeks of starting treatment",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Human immunodeficiency virus (HIV)-infected",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "History of prior tuberculosis or history of previous tuberculosis treatment",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Pregnant or breastfeeding",
      "label": "not_met",
      "evidence": "patient text"
    },
    {
      "criterion": "Cavitary tuberculosis on initial chest X-ray (taken within 14 days of study entry)",
      "label": "triggers",
      "evidence": "chest X-ray findings"
    },
    {
      "criterion": "Exposure to person(s) with known drug resistant tuberculosis",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Patients receiving chronic steroids or other immunosuppressive medications",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Extra-pulmonary tuberculosis",
      "label": "not_met",
      "evidence": "patient text"
    },
    {
      "criterion": "Patients with drug resistant tuberculosis (resistance to isoniazid (INH), rifampicin, pyrazinamide or ethambutol)",
      "label": "triggers",
      "evidence": "sputum culture results"
    }
  ],
  "notes": "Patient has newly diagnosed initial episodes of pulmonary tuberculosis with confirmed diagnosis by culture. Chest X-ray and clinical findings are consistent with tuberculosis. Patient is ambulatory and willing to receive supervised anti-TB treatment.",
  "_meta": {
    "topic_id": "46",
    "trial_id": "NCT00130247",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}